Back to search

Article

Prostate cancer-induced endothelial-to-osteoblast transition generates an immunosuppressive bone tumor microenvironment

2023-12-02

Abstract excerpt

Immune checkpoint therapy has limited efficacy for patients with bone metastatic castrate-resistant prostate cancer (bmCRPC). In this study, we revealed a novel mechanism that may account for the relative resistance of bmCRPC to immune checkpoint therapy. We found that prostate cancer (PCa)-induced bone via endothelial-to-osteoblast (EC-to-OSB) transition causes an ingress of M2-like macrophages, leading to an imm...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f01594e2-abf2-59c7-9c0a-dac55d078aa4
DOI
10.1101/2023.11.30.569496
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prostate cancer-induced endothelial-to-osteoblast transition generates an immunosuppressive bone tumor microenvironmentDOI 10.1101/2023.11.30.569496
Select a neighboring publication to make it the new centre.